• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of new or reformulated infant formula notification reviews completed during the month within 90 days of filing

Dictionary: Timely review of notifications for new and reformulated infant formulas is essential for protecting the health and well being of infants. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of March 31, 2014.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 20109080
Nov 201090100
Dec 201090100
Jan 201190N/A
Feb 201190100
Mar 201190100
Apr 201190100
May 201190100
Jun 201190100
Jul 201190100
Aug 201190100
Sep 201190100

FY 2011 Overall: 97%

Number of new or reformulated infant formula notification reviews due to be completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A5
Nov 2010N/A2
Dec 2010N/A1
Jan 2011N/A0
Feb 2011N/A4
Mar 2011N/A4
Apr 2011N/A1
May 2011N/A3
Jun 2011N/A2
Jul 2011N/A4
Aug 2011N/A2
Sep 2011N/A10

FY 2011 Total: 38

Number of infant formula notification reviews completed during the month within 90 days of filing

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A4
Nov 2010N/A2
Dec 2010N/A1
Jan 2011N/AN/A
Feb 2011N/A4
Mar 2011N/A4
Apr 2011N/A1
May 2011N/A3
Jun 2011N/A2
Jul 2011N/A4
Aug 2011N/A2
Sep 2011N/A10

FY 2011 Total: 37

Total number of infant formula notification reviews completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A5
Nov 2010N/A2
Dec 2010N/A1
Jan 2011N/AN/A
Feb 2011N/A4
Mar 2011N/A4
Apr 2011N/A1
May 2011N/A3
Jun 2011N/A2
Jul 2011N/A4
Aug 2011N/A2
Sep 2011N/A10

FY 2011 Total: 38

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.